Found 468 clinical trials
Registry of Asthma Patients Initiating DUPIXENT
The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting. The secondary objectives of the study are: To characterize real-world use patterns of DUPIXENT for asthma To assess the long-term effectiveness of DUPIXENT in asthma patients in a …
- 0 views
- 16 Feb, 2024
- 1 location
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
To evaluate the time-course of AD and selected atopic comorbidities. Secondary Objectives: To characterize disease burden and unmet need. To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching).
- 0 views
- 22 Feb, 2021
- 18 locations
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
The primary aim is to compare differences in anxiety and depression scores of pregnant women between countries affected by the COVID-19 pandemic. The secondary aim is to assess demographic, economic, and social aspects affecting maternal anxiety and depression scores among pregnant women worldwide in the time of the COVID-19 pandemic.
- 0 views
- 05 Aug, 2020
Observational Study of Adult Patients Receiving Dupixent for Atopic Dermatitis (AD)
Primary Objective: To characterize the patients who receive Dupixent (dupilumab) for AD in a real-world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD Secondary Objectives: To characterize real-world use patterns of Dupixent for AD (eg, used regimens, reason for initiation …
- 0 views
- 25 Feb, 2021
- 19 locations
Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children
School resumed on May 11th for primary school children and on June 2nd for secondary school children. In this survey, we aim at exploring the psychological status of these children and the impact on their schooling, for better understanding, support and prevention.
- 0 views
- 05 Aug, 2020
Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020
Primary endpoint: Estimate 1-year- and 5-year-mortality rates in patients with PLC. Secondary endpoints: Describe PLC patient population managed by pulmonologists at French General Hospitals in 2020 Describe PLC diagnostic and therapeutic management by pulmonologists at French General Hospitals in 2020 and compare them to KBP-2000-CPHG and KBP-2010-CPHG studies Estimate prognostic …
- 0 views
- 16 Feb, 2024
- 1 location
EffectS of CAnnabidiol in Patients: Evaluation
The main objective of the study is therefore to assess the prevalence of CBD users in algology and addictology departments. Secondary objectives are to characterize the use of CBD as well as the users of CBD, and to evaluate the impact of the use of CBD on other psychoactive substances …
- 0 views
- 16 Feb, 2024
- 1 location
Drug Coated Balloon Only vs Drug Eluting Stent Angioplasty
We will, incorporate all patients presenting either with myocardial infarction (heart attack) or stable angina. Our main outcomes will be: Primary 1) mortality Secondary 1) cardiac mortality 2) cardiac rehospitalisation3) composite of cardiac mortality and cardiac rehospitalisation
- 0 views
- 05 Aug, 2020
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …
- 0 views
- 12 Nov, 2020
- 10 locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …
- 0 views
- 16 Feb, 2024
- 4 locations